The Open Payments database managed by the Centers for Medicare & Medicaid Services (CMS) is regarded as the principal method used by the federal government to monitor the financial relationships in the healthcare industry. This manual will assist you in comprehending the operation of the Open Payments database, the useful insights that can be gained from the data, and who knows, maybe even bringing it out to your benefit, if you are a patient, a policy researcher, or an investigative reporter.

What Is the Open Payments Database?

The Open Payments program was originally set up by the Physician Payments Sunshine Act, which is incorporated in the Affordable Care Act. The intention of the program is very simple: to reveal the money exchanged between the industry and the professionals and to make it public knowledge in case of teaching hospitals.

At its core, the database tracks:

• Payments from pharmaceutical companies
• Payments from medical device manufacturers
• Transfers of value to physicians and teaching hospitals
• Financial relationships such as consulting fees, travel, meals, royalties, and research funding
• Ownership or investment interests held by physicians in industry companies

The database is U.S. federal, updated annually, and operated by CMS—the same agency that runs Medicare, Medicaid, and other major national healthcare programs.

Transparency is the primary goal. The data does not determine whether a payment is inappropriate; it simply documents the relationship.

Who Is Included in the Open Payments Database?

Open Payments covers three main groups:

Physicians

CMS tracks payments to:

• Medical doctors (MD)
• Doctors of osteopathic medicine (DO)
• Dentists, podiatrists, and optometrists in certain cases
• Chiropractors and other specialties when they fall under federal rules

Physician assistants and nurse practitioners were added more recently, expanding the database’s reach.

Teaching Hospitals

Any hospital that gets Medicare’s graduate medical education payments is viewed as a teaching hospital. These organizations are important because they run clinical trials, get huge research grants, and are frequently in partnership with medical device companies.

Applicable Manufacturers

These include:

• Pharmaceutical companies
• Biologic manufacturers
• Medical device companies
• Entities involved in drug or device marketing

Payments must be reported even if they are as minor as a meal at a conference or as large as a multi-year consulting arrangement.

Types of Payments Reported

Payments are categorized into three core groups:

1. General Payments

These include:

• Consulting fees
• Travel and lodging
• Meals
• Speaking engagements
• Education payments

For example, a neurologist who participates in a device advisory board might receive a $600 consulting fee—this would appear as a general payment.

2. Research Payments

These cover:

• Clinical trial funding
• Study-related support
• Research grants

Payments may go directly to a physician or through a medical institution.

3. Ownership or Investment Interests

Physicians who own equity in a company—stock, partnership stakes, or other investments—are included here. This is one of the most scrutinized areas because it can create complex or opaque financial incentives.

How to Use the Open Payments Database Search Tool (Step-by-Step)

CMS designed Open Payments for both casual use (simple name search) and advanced analysis (full dataset downloads). Below is a practical walkthrough.

Step 1 — Access the Open Payments Database

Go to the Open Payments Search Tool, where the landing dashboard allows you to look up physicians, hospitals, companies, or products.

Step 2 — Search by Physician or Hospital

For patients and journalists, this is usually the most relevant entry point.

You can search by:

• Physician name
• City and state
• Specialty
• Teaching hospital name

Results show:

• Total amount received
• Payment types
• Number of transactions

Each physician has a profile page summarizing their financial relationships.

Step 3 — Search by Company or Product

If you want to investigate how a specific manufacturer distributes money—e.g., marketing a new diabetes drug—search by company name or product name.

Useful for:

• Market analysis
• Conflict-of-interest reporting
• Cross-industry comparisons

Step 4 — Explore Detailed Open Payments Database Records

Opening a payment record reveals granular information:

• Amount
• Payment date
• Payment category
• Associated product
• Context (e.g., “food and beverage at conference dinner”)

Even small payments—like a $32 meal—must be reported.

Important note: small payments often accumulate into significant totals over hundreds of interactions.

Step 5 — Download Bulk Data (CSV / Full Dataset)

For deeper research, CMS allows full bulk downloads.

Includes:

• Flat files for each payment type
• A data dictionary
• Year-by-year structured datasets

The data is large, often requiring specialized software to analyze effectively.

Understanding the Open Payments Database Data—and Its Limits

The Open Payments database is robust, but like all large administrative datasets, it has boundaries you should understand before drawing conclusions.

1. Self-Reported Information

Manufacturers submit their own data, which CMS later audits. Errors can occur, though disputes are processed and corrected annually.

2. Missing Specialties

Certain healthcare professions are not included (e.g., some allied health professionals), and reporting requirements evolve over time.

3. Reporting Thresholds

Small facilities or rare payment types may not meet reporting minimums.

4. No Judgment on Appropriateness

The database does not label payments as ethical or unethical—it only provides transparency.

Practical Use Cases of the Open Payments Database

For Patients

• Evaluate whether your doctor has financial ties to companies whose products they recommend.
• Compare payment patterns across specialties or regions.

Journalists

• Investigate potential conflicts in clinical decision-making.
• Link payment patterns to prescribing behavior or research participation.
• Build data-driven accountability stories.

Researchers & Policy Analysts

• Analyze sector-wide trends (e.g., cardiology vs. oncology payments).
• Examine the commercialization of medical technology.
• Compare research vs. marketing payments.

Compliance Officers

• Benchmark your organization against peers.
• Track industry relationships for internal reporting.
• Identify potential areas of regulatory risk.

Tips for Accurate Interpretation

• Always check whether payments are general or research.
• Avoid assuming causation based on correlation.
• Look at trends across multiple years rather than single data points.
• Verify unusually high payments by reviewing record details.
• Cross-check related datasets for context (Medicare, clinical trials, FDA safety data).

How Often Does CMS Update the Open Payments Database?

CMS updates the database annually, typically following this cycle:

• Spring: Manufacturers submit data
• Summer: Dispute and correction period
• Late summer / early fall: Publication of new data
• Ongoing: Historical corrections and auditing

Each annual dataset includes all payments from the previous calendar year.

Open Payments Database FAQ

Are All Doctors Included in the Open Payments Database?

Most physicians are included, but not all. Some specialties or practitioners may be outside the reporting scope.

Does receiving payments indicate wrongdoing?

Not necessarily. Many payments reflect research funding, education, product training, or collaborations.

How reliable is the data?

It is self-reported but audited by CMS. Disputes and corrections are part of the annual update cycle.

Can I Download the Full Open Payments Database Dataset?

Yes. Bulk files are available for each year in CSV format.

Conclusion

The Open Payments Database is a major transparency tool in the U.S. healthcare system, and it is now used more widely than ever. It reveals the financial connections between physicians and the medical industry, and as a result it gives patients, researchers, journalists, and compliance officers clearer insight, better questions to ask, and more informed decision-making power.

When used properly—along with other data sets such as Medicare payment policies, FDA adverse event reports, and clinical trial registries—it gives a clearer picture of how much financial drivers influence the American healthcare system.

Related Database

• Clinical Trial Databases guide
• NPPES NPI Registry overview
• Health Databases collection
• Medicare Coverage Database guide

Sources

1. Centers for Medicare & Medicaid Services (CMS) – Open Payments Program Overview
   https://www.cms.gov/openpayments
2. Open Payments Data Portal (CMS) – Search Tool & Bulk Data
   https://openpaymentsdata.cms.gov/
3. Physician Payments Sunshine Act – Federal Register Final Rule (42 CFR Part 403)
   https://www.federalregister.gov/documents/2013/02/08/2013-02572/medicare-medicaid-childrens-health-insurance-programs-transparency-reports-and-reporting-of-physician
4. Government Accountability Office (GAO) – CMS Oversight of Open Payments Data
   https://www.gao.gov

This article was created with AI assistance and reviewed by a human editor.

The post Open Payments Database: What Doctors Are Really Paid appeared first on The Database Search.

The article explains what PubChem is and how the professionals depend on it and how you can make use of it to take smarter, safer, and more informed decisions in research, industry, or even everyday life.

What Is the PubChem Database?

PubChem is the largest free chemistry database in the world, which is managed by the National Center for Biotechnology Information (NCBI) at the U.S. National Institutes of Health (NIH).

As per the official documentation of the project, more than 100 million chemical records are stored in PubChem containing various data types such as chemical structures, identifiers, safety and biological activity data, toxicology profiles, and references to thousands of scientific sources (PubChem About, NCBI).

The database is built for a very basic yet very powerful goal:
To make chemical information very open and accessible—very accurately, very transparently, and at very large scale.

The credibility of the database is based on the large number of reliable contributors: government agencies (like EPA, FDA, CDC), universities, pharmaceutical companies, environmental laboratories, and international research bodies.

Why the PubChem Database Matters (Even If You’re Not a Chemist)

PubChem’s value becomes obvious when you realize how many scientific questions hinge on knowing a single chemical’s structure or toxicity.

Consider these everyday use cases:

• Drug formulation scientists check drug–drug interactions and molecular pathways.
• Environmental researchers evaluate pesticides in water or air samples.
• Physicians and pharmacists verify medication risks and contraindications.
• Regulatory professionals review hazard classifications and exposure limits.
• Journalists investigate chemicals found in consumer products.
• Consumers look up toxicity information (e.g., “Is BPA dangerous?”).

Whenever you need to identify a substance, understand how it behaves, or determine whether it’s hazardous, PubChem is the authoritative starting point.

How the PubChem Database Is Structured: Three Core Record Types

PubChem organizes its information into three major record types:

1. Substance Records (SID)

Submitted by data providers such as labs, manufacturers, or agencies.
Useful for comparing how different organizations describe the same chemical.

2. Compound Records (CID)

Standardized structures created by PubChem by merging identical substances.
These are the most commonly viewed records.

3. BioAssay Records (AID)

Contain detailed test results on how chemicals behave in biological systems.

Together, these form a multi-layered dataset that supports both high-level browsing and advanced scientific analysis.

What You Can Find in a PubChem Database Record

(Using the Example of Acetaminophen – CID 1983)

To illustrate how deep PubChem’s data goes, let’s walk through a concrete example using a well-known compound: acetaminophen, the active ingredient in Tylenol.

When you search “acetaminophen” in PubChem, you’ll see tabs covering:

1. Structures

• 2D structural diagrams
• 3D conformers
• SMILES, InChI, and InChIKey identifiers
• Isomer and stereochemistry information

This is foundational for computational chemistry, drug design, and regulatory identification.

2. Names and Identifiers

Includes:

• Synonyms (e.g., paracetamol)
• CAS number
• UNII code
• EC and ECHA identifiers

This is especially valuable when comparing regulations across countries.

3. Chemical and Physical Properties

PubChem provides experimentally measured or predicted properties, such as:

• Molecular weight
• Melting point
• Boiling point
• LogP
• Solubility
• Vapor pressure

For acetaminophen, you’ll find its moderately high melting point and low vapor pressure—properties that influence formulation, stability, and environmental behavior.

4. Spectral Information

This is one of PubChem’s under-appreciated strengths.
You can access:

• NMR spectra
• IR spectra
• UV–Vis datasets
• Mass spectrometry profiles

Environmental chemists, forensic labs, and academic researchers rely on these to identify unknown samples.

5. Chemical Vendors

If you need to purchase a substance, PubChem lists verified suppliers, helping avoid counterfeit or mislabeled chemical products.

6. Drug and Medication Information

For pharmaceuticals, PubChem integrates:

• Mechanism of action
• Therapeutic uses
• Dosage forms
• Regulatory status

For acetaminophen, you’ll find FDA drug label references and links to the DailyMed database.

7. Pharmacology and Biochemistry

Includes:

• Metabolic pathways
• Target receptors or enzymes
• ADME profiles
• Bioactivity summaries

This data is critical for drug discovery and toxicology.

8. Safety and Hazards

PubChem imports or aggregates:

• OSHA classifications
• GHS hazard statements
• NFPA ratings
• Flammability, reactivity, instability data
• First-aid measures
• Fire-fighting instructions

This section alone makes PubChem indispensable for workplace safety programs.

9. Toxicity

Here you’ll find:

• Acute toxicity (LD50, LC50)
• Chronic toxicity
• Carcinogenicity, mutagenicity
• Reproductive toxicity
• Environmental toxicity (aquatic, terrestrial)

For acetaminophen, PubChem notes hepatotoxicity risks at high doses—reinforced by NIH and FDA references.

10. Associated Disorders and Diseases

PubChem links chemicals to:

• Related diseases
• Medical conditions
• Known adverse effects

For acetaminophen, this includes liver failure and overdose-related complications.

11. Literature and Patents

PubChem integrates:

• Peer-reviewed papers
• Clinical studies
• Patent documents from USPTO, EPO, WIPO

This allows researchers to trace a chemical’s development over decades.

12. Interactions and Pathways

PubChem connects chemicals to:

• Biological pathways (via KEGG, Reactome, etc.)
• Protein interactions
• Metabolic systems

For example, acetaminophen metabolism through CYP450 enzymes appears here with clear pathway visualizations.

13. Biological Test Results

These include results from NIH’s high-throughput screening programs and hundreds of bioassays.

Who Uses the PubChem Database—and Why It’s Become a Default Industry Tool

Pharmaceutical Companies

To validate compound identities, check pre-existing literature, and review toxicity.

Regulatory Agencies

EPA, FDA, ECHA, and OSHA rely on PubChem as a reference point for standard identifiers.

Environmental Scientists

To track contaminants, pesticides, industrial chemicals, and emerging pollutants.

Academics

For research, coursework, and experimental planning.

Consumer Safety Groups

To investigate chemicals used in cosmetics, food packaging, and household products.

Data Scientists

To build chemical models, run QSAR predictions, or integrate chemical attributes into machine-learning systems.

Strengths of the PubChem Database (From a Practitioner’s Perspective)

1. Completely Free and Open Access in the PubChem Database

No paywalls, no login required.
This democratized chemical information long before “open science” became a trend.

2. Built on Trusted Sources

NIH, EPA, FDA, CDC, academic research labs, international agencies, and industry contributors.

3. Interlinked Biological and Clinical Data in the PubChem Database

You can move seamlessly from a chemical structure to bioassay results to FDA drug labels.

4. Exceptional Scale

It is, by far, the largest open chemical database in the world.

5. Transparent Data Sources in the PubChem Database

Every data point lists its source—critical for regulatory or scientific work.

Limitations of the PubChem Database You Should Know

PubChem is excellent, but not perfect.

• Not all chemicals have complete experimental property datasets.
• Some data—especially spectral information—may come from older records.
• PubChem aggregates from many sources, so terminology sometimes varies.
• Regulatory classifications differ across countries and may not always align.

For critical safety or legal decisions, PubChem should be paired with primary regulatory sources (OSHA, EPA, NIOSH, FDA).

Practical Tips for Using the PubChem Database Effectively

1. Always Check the Source List

Located at the bottom of each record—this tells you where the information originally came from.

2. Use the “Download” Feature

You can export structures in .sdf, .mol, .csv, .xml, and other formats.

3. Compare Multiple Substance Records

If data differs between providers, this can indicate:

• multiple grades of a chemical
• manufacturing differences
• measurement variability

4. Use Filters to Narrow Down BioAssay Data

Many compounds have hundreds or thousands of test results; filters save hours.

5. Explore “Related Compounds”

This is incredibly useful for drug design and material-science research.

Conclusion: Why the PubChem Database Still Matters

The PubChem database has been a great help to students, scientists, regulators, and even ordinary people. It has converted an enormously complicated issue—chemical information—into something that can be accessed, traced, and used in very practical ways. The very thoroughness of its records, the trustworthiness of its sources, and the openness of its access model make it indispensable to today’s science.

No matter if you are doing a compound verification prior to its synthesis, a toxicity check before a field experiment, or just trying to get a clearer picture of the substances present in a consumer product—PubChem is a very powerful tool that not only should be but also is in fact the very core of every researcher’s work.

If you’re exploring broader public-health data, you can also check our Health Databases section and our guide to the Chemical Contaminants Transparency Tool for deeper context.

Sources Used for the PubChem Database Guide

• PubChem / NCBI — About PubChem
  https://pubchem.ncbi.nlm.nih.gov/docs/about
• U.S. National Library of Medicine (NIH) – PubChem data ecosystem
  https://www.ncbi.nlm.nih.gov/
• FDA DailyMed drug labeling database
  https://dailymed.nlm.nih.gov/dailymed/
• EPA CompTox Chemicals Dashboard (regulatory cross-reference)
  https://comptox.epa.gov/dashboard

This article was created with AI assistance and reviewed by a human editor.

The post PubChem Database: The Chemical Clues We Almost Missed appeared first on The Database Search.

Whether you’re a researcher tracing PFAS degradation pathways, a journalist verifying hazard classifications, or a regulatory analyst evaluating screening-level risks, the CompTox Chemicals Dashboard provides enough detail to anchor real decisions, not just theoretical speculation.

This article walks through how the dashboard works, why it matters, and how to use its most advanced features — illustrated with specific examples and grounded in EPA’s published documentation.

What Is the CompTox Chemicals Dashboard?

The EPA’s public chemical dashboard is a publicly accessible web database developed by the EPA’s Office of Research and Development to centralize chemical information across multiple scientific domains.

According to EPA’s official materials, the dashboard aggregates:

• Chemical structures
• Experimental physicochemical properties
• Predicted properties generated by computational models
• Environmental fate data
• Hazard and bioassay results
• Exposure predictions
• Toxicokinetic and IVIVE models
• Links to external regulatory and scientific resources

The tool draws heavily from the Distributed Structure-Searchable Toxicity (DSSTox) database — EPA’s curated chemical identifier warehouse — and supplements it with data from authoritative sources like PubChem, the National Library of Medicine, ToxCast/Tox21, the GHS classification system, and EPA internal assay programs.

EPA notes that Dashboard data undergoes iterative review and expansion with each release (EPA, 2022), which means the resource is continuously growing in scope and reliability.

Why the CompTox Chemicals Dashboard Matters

The value of the Dashboard shows up most clearly when you think about what doesn’t exist elsewhere:

1. It brings disparate chemical data into one place

Federal agencies, industry reports, academic datasets, REACH filings, and internal toxicology programs all speak different “data languages.”
CompTox is one of the few tools designed to unify these threads into a single, structure-anchored view.

2. It supports screening-level assessments at scale

EPA explicitly designed the Dashboard to accelerate hazard evaluation and prioritization — crucial for the agency’s TSCA responsibilities and environmental health research.

3. It aids exposure science and computational toxicology

Assays, IVIVE models, rapid predictions, and curated structures provide the foundation for modern exposure and toxicity modeling used across universities and government labs.

4. It gives the public access to datasets once available only to regulators

This includes bioactivity summaries, environmental fate models, product-use context, and link-outs to regulatory documents — tools rarely available in a single open interface.

In short, the Dashboard is both a transparency instrument and a scientific workbench.

How to Search in the CompTox Chemicals Dashboard

The Dashboard offers three primary search pathways, each designed for a different type of user inquiry.

1. Chemicals Search

This is the most commonly used entry point.

You can search by:

• Systematic name
• Synonym or common name
• CAS Registry Number
• DTXSID (EPA’s curated chemical identifier)
• InChIKey

The search bar supports three modes:

• Type-ahead search

Begins suggesting chemicals as soon as you start typing.
Useful when exploring variations of a chemical name or spelling.

• Exact search

Returns results only when the identifier matches exactly.

• Identifier substring search

Particularly valuable for partial CAS numbers or incomplete identifiers during investigative research.

When you select a chemical from the dropdown list, a detailed profile opens showing multiple panels of scientific data.

2. Product / Use Categories Search

This view allows you to browse chemicals grouped by:

• Consumer products (e.g., “cosmetics,” “cleaning agents”)
• Industrial applications
• Functional uses (e.g., “plasticizer,” “flame retardant”)

This is vital for journalists and researchers tracking chemical presence in consumer markets, product safety, or industrial supply chains.

3. Assay / Gene Search

Search by:

• Assay endpoint name
• Gene symbol

This connects you directly to ToxCast/Tox21 data, enabling quick screening of bioactivity or molecular target interactions—an essential feature for computational toxicologists and pharmacologists.

What You See in a CompTox Chemicals Dashboard Profile: A Breakdown

When you click into a chemical record — for example, Bisphenol A (BPA) or Perfluorooctanoic acid (PFOA) — the Dashboard typically displays the following modules:

1. Chemical Details

This includes:

• DSSTox identifier (DTXSID)
• Structural formulas
• Synonyms
• CAS number
• Known isomers or mixtures
• Source curation notes

This section is sourced directly from DSSTox, EPA’s flagship structure-based chemical registry.

2. Executive Summary

A concise overview of:

• Chemical identity
• Major use cases
• Regulatory relevance
• Data availability

This is particularly useful for quick briefings or scoping work.

3. Physicochemical Properties

The Dashboard lists:

• Experimental measurements (where available)
• Predicted values (LogP, water solubility, vapor pressure, Henry’s Law constant)
• Method notes
• Data sources

These parameters anchor exposure modeling and environmental fate predictions.

4. Environmental Fate & Transport

Here you may find:

• Biodegradation outcomes
• Partitioning behavior
• Multimedia transport models
• Persistence indicators

EPA often links to supporting tools such as the EPA Water Pollution Search or the EPISuite models.

5. Hazard Data

Includes:

• Acute toxicity
• Chronic endpoints
• Carcinogenicity classifications
• Reproductive or developmental toxicity
• ToxRefDB outputs
• ToxCast data summaries

This is where many regulatory professionals start their review.

6. Safety > GHS Data

Provides:

• Globally Harmonized System (GHS) hazard classes
• Precautionary statements
• Pictograms
• Classification sources

This section is crucial for workplace safety compliance and SDS preparation.

7. ADME / IVIVE

The IVIVE (in vitro–in vivo extrapolation) module estimates:

• Plasma binding
• Clearance
• Modeled human equivalent doses

EPA highlights that these estimates support early-stage toxicity screening (EPA CompTox Resource Hub).

8. Exposure

Exposure predictions may include:

• Modeled population exposures
• Intake estimates
• Pathway breakdowns
• Uncertainty indicators

These come from EPA exposure databases and high-throughput exposure models.

9. Bioactivity

Drawn primarily from ToxCast/Tox21, this section provides:

• Assay hit calls
• Dose-response curves
• Affected biological pathways

Researchers often use these data to evaluate biological plausibility in toxicology studies.

10. GenRA

The Generalized Read-Across (GenRA) tool uses structural similarity to evaluate potential hazards in data-poor chemicals.

This is an advanced feature relevant for:

• Alternatives assessment
• Rapid screening
• TSCA prioritization research

11. Literature

Direct connections to:

• EPA reports
• Academic papers
• External scientific databases
• Systematic reviews

This section is especially powerful for journalists and researchers verifying claims about chemical risk.

12. External Links & Regulatory Data

You’ll often see links to:

• PubChem
• NLM TOXNET archives
• ECHA REACH registrations
• NIST
• OECD tools
• Other EPA platforms

This transforms the Dashboard into a central navigation hub for chemical intelligence.

Practical Ways to Use the CompTox Chemicals Dashboard

1. Rapid Screening of Chemicals in Supply Chains Using the CompTox Chemicals Dashboard

Manufacturers can use product-category searches to identify chemicals of concern in consumer products.

2. Supporting Academic Research with the CompTox Chemicals Dashboard

Graduate students often rely on Dashboard data for:

• Physchem parameter extraction
• Bioactivity comparisons
• IVIVE modeling inputs

3. Verification for environmental journalism

Reporters frequently use the GHS, hazard, and literature tabs when fact-checking chemical risk claims.

4. Early-stage risk prioritization

Regulatory analysts use DSSTox identifiers and GenRA outputs to identify data gaps and structurally similar substances.

5. Public interest and community science

Residents concerned about local contamination (PFAS, chlorinated solvents, heavy metals) can use the tool to understand chemical behavior and documented hazards.

Strengths and Limitations

Strengths of the CompTox Chemicals Dashboard

• Unusually broad data coverage (over one million substances).
• Curated structure-matched identifiers reduce ambiguity.
• Regular updates keep the platform aligned with current science.
• Strong transparency value for the public.

Limitations of the CompTox Chemicals Dashboard

• Not all chemicals have complete datasets — many entries rely on predicted values.
• Gaps remain for niche endpoints or rare compounds.
• Exposure models reflect assumptions and uncertainties inherent to rapid screening.

EPA itself notes ongoing efforts to expand the dataset, refine models, and improve coverage (EPA, 2022).

Conclusion: Why the CompTox Chemicals Dashboard Matters

The CompTox Chemicals Dashboard is one of the most powerful, publicly accessible chemical intelligence tools in the United States. It consolidates curated identifiers, environmental models, bioactivity results, hazard classifications, literature, and exposure predictions into a single interface — something no commercial database fully replicates.

For scientists, regulators, journalists, and community advocates, it offers not just data but context — information grounded in EPA science, structured for practical decision-making, and transparent enough to support public inquiry.

If you work with chemicals in any capacity, the Dashboard is not just a useful tool — it’s a necessary one.

For readers exploring related environmental and food-safety tools, see our guide to the Chemical Contaminants Transparency Tool and the Organic Integrity Database, or browse all of our free and open databases.

Sources for the CompTox Chemicals Dashboard Guide

• U.S. Environmental Protection Agency. About EPA. https://www.epa.gov/aboutepa
• EPA’s official dashboard Overview.
• EPA. CompTox Resource Hub. https://www.epa.gov/comptox-tools/comptox-chemicals-dashboard-resource-hub
• EPA. Distributed Structure-Searchable Toxicity (DSSTox) Database. https://www.epa.gov/comptox-tools/distributed-structure-searchable-toxicity-dsstox-database
• EPA. Chemical Dashboard March 2022 Report. https://www.epa.gov/system/files/documents/2022-06/chemicals_dashboard_march2022.pdf
• EPA Science Inventory: Dsstox Publications. https://cfpub.epa.gov/si/si_lab_search_results.cfm
• EPA CompTox Seminar. Understanding the Dashboard (YouTube). https://www.youtube.com/watch?v=ObANKz_iWRI

This article was created with AI assistance and reviewed by a human editor.

The post CompTox Chemicals Dashboard: What EPA Data Really Shows appeared first on The Database Search.

What is the TravelingWiki Airport Database?

The TravelingWiki Foundation has developed and is maintaining a community-based not-for-profit database with the purpose of normalizing the airport experience for all travelers. It especially seeks to help individuals with sensory sensitivities or other accessibility needs.

Who is the CEO of TravelingWiki?

This initiative was developed by Jonathan Sutter, J.D., M.B.A., who recognized that airport websites generally do not provide all the information travelers require – such as where to locate a quiet waiting area or how to get from long-term parking to the terminal without getting lost or completely overwhelmed Sinai Denver, 2024.

A Human-Centered Approach to Data

Unlike most commercial flight directories that prioritize airlines and departure gates, TravelingWiki starts with people. Each airport page provides detailed, often crowdsourced data on:

• Terminal layouts
• Parking structures and shuttle services
• Dining options (with noise level and food type indicators)
• Security line locations
• Accessibility features like sensory rooms or companion care restrooms
• Language and signage clarity
• Emergency procedures and contact points

The result is a holistic view of the airport as experienced by real people.

“We aim to reduce stress, increase predictability, and improve autonomy for all airport users,” says Sutter.

Coverage: From the 10 Busiest Airports to 150 by Year-End

As of early 2025, TravelingWiki has information on the 10 busiest US airports, including Atlanta (ATL), Los Angeles (LAX), Chicago O’Hare (ORD), and Dallas/Fort Worth (DFW) EIN Presswire, 2025. The company has stated publicly to have the goal of having 150 US airports covered before the end of 2025, with the intent of having operational areas in both the major hubs and also those underserved regional locations.

The reach is built through a combination of airport collaboration, stakeholder and volunteer input, and partnerships with travel-focused non profit organizations.

A Quiet Revolution in Airport Accessibility: Inside the TravelingWiki Airport Database

Accessibility at airports has long been an afterthought. While the Americans with Disabilities Act (ADA) mandates certain structural features, the lived experience of navigating a massive terminal with autism, anxiety, or mobility challenges is still daunting.

TravelingWiki tackles this gap not with marketing slogans, but with hard data and lived experience. For example:

• Phoenix Sky Harbor‘s page details which terminal offers the most natural light and the quietest gate areas.
• Newark Liberty International includes information on where travelers with sensory needs can find low-stimulation zones.

By highlighting this kind of information, TravelingWiki isn’t just mapping spaces – it’s making them navigable and humane.

Why the TravelingWiki Airport Database Matters: A Real Example

Imagine you’re a parent traveling with a 7-year-old on the autism spectrum. You’re landing at LAX and need to know: where can we decompress after a 4-hour flight? What terminal has the fewest fluorescent lights? Which bathrooms offer private changing areas?

TravelingWiki answers these questions with detailed, firsthand descriptions that mainstream platforms ignore. This empowers travelers with predictability, a key component of neurodivergent-friendly travel.

Technical Simplicity, Functional Power

The website itself, travelingwiki.com, is clean, ad-free, and fast. There are no intrusive popups or tracking cookies. Instead, pages load quickly and offer easy-to-scan sections:

• “Getting There”
• “Inside the Terminal”
• “Dining & Amenities”
• “Quiet Zones”
• “Accessibility Notes”

And there is even an option to make suggestions and corrections so it is a true community platform. Plus, it is multilingual, available in 10+ languages (including Spanish, Mandarin, and Arabic) to support the diversity of travelers we see in U.S. airports.

How It Compares to Other Airport Databases

While most platforms prioritize logistics or real-time data, TravelingWiki’s strength lies in comprehensive human-centered guidance.

Challenges and Limitations

As a community-driven resource, TravelingWiki depends on volunteers to constantly update the data, so these entries may be incomplete for smaller airports, and not all entries are independently validated. Even though TravelingWiki is open-source, it has limitations on how quickly the software can develop compared to commercial options.

That said, the platform’s transparency and open editing process help mitigate misinformation. Contributions are reviewed, and feedback mechanisms are actively monitored.

How to Use the TravelingWiki Airport Database Efficiently

1. Search your airport in advance (e.g., “LAX TravelingWiki”).
2. Use the terminal maps to locate preferred amenities.
3. Check the “Accessibility Notes” for sensory guidance.
4. Look up transport and parking to reduce arrival stress.
5. If your airport isn’t listed yet, submit a request or share local info.

Final Thoughts: A Blueprint for What Airport Info Should Be

TravelingWiki isn’t perfect, but it’s a genuinely helpful, user-first airport database that fills a critical gap in the travel experience. Its open structure, focus on accessibility, and practical design make it stand out in a space dominated by airline-centric tools.

For travelers who crave not just directions but reassurance, TravelingWiki Airport Database is a small revolution – and one well worth supporting.

Discover more ESG-focused resources like the TravelingWiki airport database in our dedicated section: ESG databases.

Sources

• EIN Presswire: TravelingWiki Now Covers the 10 Busiest US Airports
• Sinai Denver: Introduction of TravelingWiki.com as a Non-Profit Resource
• TravelingWiki official site: https://travelingwiki.com

The post TravelingWiki Airport Database: What Airports Won’t Tell You appeared first on The Database Search.

If you’ve ever considered the questions below:

• “How many young adults have died from alcohol-related liver disease, in the previous ten years?”
• “Is there a geographical pattern to asthma-related deaths in the U.S.?”
• “Have Native American suicide rates increased since COVID-19?”

Then you’re already thinking like an epidemiologist! And the CDC WONDER database is there for you.

In this article, we’ll discuss what the CDC WONDER database is, how to use it, and why it’s one of the most poorly utilized public health tools in the USA.

What Is the CDC WONDER Database?

CDC WONDER, or Wide-ranging Online Data for Epidemiologic Research, is an online system developed by the Centers for Disease Control and Prevention (CDC), that provides the public with access to a good deal of health-related datasets.

The WONDER database was created in the mid-1990s for use by researchers, reporters, policy-makers, and even, by engaged citizens looking for accurate, timely, and micro-level health data on things like:

• Mortality and causes of death
• Birth and fertility rates
• Cancer statistics
• Hospital discharge records
• Population estimates

The system allows users to generate customized reports, export data for analysis, and explore trends over time or across geographic regions.

Why It Matters: A Real-World Example Using the CDC WONDER Database

In 2024, researchers used CDC WONDER to analyze trends in alcohol-associated liver disease (ALD) deaths. Their study, published in JAMA Network Open, found a significant increase in ALD mortality in the U.S. between 2017 and 2022—especially among women, young adults, and American Indian/Alaska Native communities source.

The data came directly from the Multiple Cause of Death (MCD) public use dataset within CDC WONDER. Without this public resource, tracking patterns like this would be nearly impossible to do on a larger scale, and would likely require months of paperwork and datasets that are not accessible to the public.

This is just one of many examples in which CDC WONDER helps provide insight on pressing public health concerns.

Key Features of the CDC WONDER Database

1. Open Access, No Login Required

The CDC WONDER database is fully open to the public—no login, subscription, or government clearance needed. Anyone with internet access can use the CDC WONDER search portal to explore detailed U.S. public health data, from mortality statistics to disease trends, all directly sourced from the CDC.

2. Powerful Search Filters

The system allows deep filtering by:

• Year (from 1999 to most recent)
• Geographic region (state, county)
• Cause of death (ICD-10 codes)
• Demographics: age group, sex, race, and ethnicity

For example, you can search for heart disease deaths among Hispanic men aged 45–64 in Texas between 2010 and 2020.

3. Data Visualization and Export

Users can see the results in tables and charts and export them into CSV format. This allows users to assimilate the results into reports, dashboards or academic work.

4. Up-to-Date and Trustworthy

The data is sourced from official death certificates and curated by the CDC. Updates are frequent and follow strict validation processes.

5. Modular System

WONDER is made up of multiple modules, such as:

• Mortality (Detailed & Compressed)
• Births
• Cancer Statistics
• Environmental data

Each module has its own custom interface and filters.

How to Use CDC WONDER: Step-by-Step

Let’s walk through a basic query:

Scenario: You want to know how many Americans aged 25–34 died from suicide in California in 2021.

Step 1: Navigate to the WONDER Mortality Database

Step 2: Choose “Detailed Mortality Data”

This provides access to more granular data than the “compressed” version.

Step 3: Set your filters:

• Group Results By: Year, Age Group, State
• Location: California
• Year: 2021
• Age: 25–34
• Cause of Death: ICD-10 code X60-X84 (Intentional self-harm)

Step 4: Submit Request

The system will provide a detailed table, the requested output, with the number of deaths, rates per 100,000 population, and confidence intervals.

You can either download the result or create visualizations with external tools such as Tableau, Excel or R.

Use Cases: Who Can Benefit from the CDC WONDER Database?

Researchers & Academics

Use it to validate hypotheses, prepare for grant applications, or support peer-reviewed publications.

Journalists & Data Storytellers

CDC WONDER is a goldmine for health-related investigative pieces, local trend analyses, and nationwide reporting.

Public Health Departments

Local governments can monitor disease outbreaks, track injury trends, and support community health initiatives.

Students

WONDER is often used in epidemiology or public health courses to teach real-world data skills.

Limitations and Caveats of the CDC WONDER Database

While WONDER is a powerful tool, it has some limitations:

• Lag in Data Availability: There’s typically a 1-year delay in finalized data.
• Suppressed Data: Small numbers (e.g., <10 cases) are often suppressed to protect privacy.
• Learning Curve: The interface isn’t as modern or intuitive as newer BI tools.

However, the CDC provides Quick Start Guides and FAQs to help new users get started efficiently.

Final Thoughts: A Tool Hiding in Plain Sight

CDC WONDER is much more than just another government program or tool. It’s a public good that can help shape health policy, support journalism and save lives.

Yet, despite all of the potential benefits, it continues to be vastly underutilized, save for specific professional research activity.

In an environment riddled with misinformation, the availability of stark data like WONDER is vital. Whether you’re a journalist working on a health story in your community, a policy analyst working on efforts to prevent opioid use and harm, or a member of the public trying to make sense of cancer patterns in your state, this data source is at your disposal.

So please don’t let the opportunity to use WONDER go to waste.

For those interested in exploring additional health-related datasets and tools, visit our full Health Databases collection, where we feature expert guides to other publicly available resources for health research, policy analysis, and data journalism.

Sources

• CDC WONDER Main Site
• CDC WONDER Help & Quick Start Guide
• CDC WONDER FAQ
• CDC WONDER Full Documentation
• JAMA Network Open Study on ALD Mortality
• EurekAlert News Release on ALD Study

The post CDC WONDER Database: The Public Health Tool You Ignore appeared first on The Database Search.

Developed by the Myrlie Evers-Williams Institute for the Elimination of Health Disparities (MEWI) at the University of Mississippi Medical Center (UMMC), this interactive tool aims to improve access to prenatal care services for expecting mothers by connecting them with available healthcare providers in their area.

Why the Mississippi Medicaid Prenatal Care Database Matters

If you’re reading this, you might assume that finding a prenatal care provider in the U.S. is as simple as a Google search. In many states, that might be true. But not in Mississippi.

In Mississippi, women are more likely than anywhere else in the country to lose a baby before its first birthday. The state also has the highest rate of maternal deaths in America. Chronic illnesses, a high number of uninsured residents, and the severe shortage of OB-GYNs in rural areas result in limited access to maternal care in many areas “maternity care deserts.”

Additionally, cases of untreated infections such as syphilis, gonorrhea, and chlamydia have increased significantly, creating additional health risks for pregnant women. According to MEWI, syphilis cases in women have skyrocketed by over 1000% in the past decade. When untreated, syphilis can lead to miscarriages, stillbirths, and severe infant complications including brain damage. And it’s preventable with a simple shot of penicillin.

A Map With a Mission: Inside the Mississippi Medicaid Prenatal Care Database

The new database—available at UMMC’s Evers-Williams Institute—features an interactive map where users can search by:

• County or ZIP code
• Clinic name or address
• Specific services offered

Each location includes a rich data profile:

• Full clinic name and address
• Google Maps link
• Phone number and website
• Opening hours
• Whether it offers prenatal care
• Family planning services
• Acceptance of Medicaid or pending Medicaid eligibility

It’s not just a list—it’s a decision-making tool designed for real-life situations. A mother-to-be in a rural county with no OB-GYN can immediately see where the nearest care facility is, how to contact them, and whether they’ll accept her Medicaid status.

Designed for People, Not Just Policymakers

There’s also a parallel version of the dashboard built specifically for providers and policymakers, allowing them to visualize gaps in service coverage and plan interventions. But the heart of this database is clearly the individual: the mother scrolling through her options, trying to find someone who will answer the phone.

If you scroll below the map on the database page, you’ll also find a county-by-county breakdown of providers, listing them by name and service category. This makes the tool accessible even for those with limited digital literacy or unstable internet connections.

Bridging the Gap Between Policy and Practice with the Mississippi Medicaid Prenatal Care Database

This tool doesn’t exist in isolation. It’s part of broader efforts to address Mississippi’s maternal health challenges. In June 2025, U.S. News and the Sitka Sentinel reported on the launch of the tool, citing it as a rare example of how technology can actually close the gap between Medicaid policy and front-line care (US News, Sitka Sentinel).

It’s also part of a broader movement toward data-driven healthcare access, aligning with other federal initiatives such as the Medicare Coverage Database that centralizes healthcare information for public use.

Practical Use: A Case Example

Imagine a 23-year-old expectant mother in rural Holmes County, Mississippi. She doesn’t have a family doctor. Her Medicaid application is still pending. Using the tool, she finds a clinic two counties over that:

• Offers both prenatal and family planning services
• Accepts pending Medicaid status
• Lists a working phone number and daily opening hours

This isn’t hypothetical. It’s exactly what the tool is designed to enable: timely, informed decisions in a system that often leaves low-income patients navigating a maze.

Final Thoughts: Small Tool, Big Impact

While online tools have limitations in addressing complex healthcare challenges, the Mississippi Medicaid Prenatal Care Database represents one approach to improving access to care. It delivers critical, localized, and timely information to the people who need it most.

The fact that it’s public, free to use, and designed with human-centered logic makes it a standout in the world of health data platforms. It addresses information gaps that often exist in Medicaid systems.

The tool represents a step toward improving access to prenatal care for expecting mothers in Mississippi.

As digital tools become more central to how Americans navigate public services, the value of transparent, user-friendly databases continues to rise. Whether you’re looking for prenatal care through Medicaid in Mississippi, exploring your options with Medicare databases, or trying to locate unclaimed policies via life insurance databases, one thing is clear: access to reliable, well-structured information is no longer a luxury — it’s a necessity.

Sources

• University of Mississippi Medical Center. “We Need to Talk” Prenatal and Family Planning Map
• US News. New online tool helps women on Medicaid find prenatal care and family planning
• Sitka Sentinel. New Online Tool Helps Women on Medicaid

The post Mississippi Medicaid Prenatal Care Database: What You’re Missing appeared first on The Database Search.

Developed by Purdue University, CDEK is not just another pharmaceutical database. It’s a transparent, open-access platform that provides an unprecedented look at every active pharmaceutical ingredient (API) with evidence of clinical testing. For researchers, regulatory professionals, and industry strategists, it has become an indispensable tool.

In this article, we’ll walk you through what the CDEK platform is, how it works, why it matters, and how it compares with other clinical data tools. We’ll also show how you can explore drug histories, trial data, organizational affiliations, and more—with real-world examples.

What Is the Clinical Drug Experience Knowledgebase?

The Clinical Drug Experience Knowledgebase (CDEK) is a curated database that provides metadata about drugs tested in clinical trials. It does not limit itself to FDA-approved drugs, making it especially useful for finding drugs in development, as well as drugs that never made it to market.

“CDEK offers insight into the hidden layer of drug development that most commercial databases miss.” — Purdue University News Release

Core Features

• APIs with Clinical Evidence: CDEK includes every drug with at least one clinical trial associated with it.
• Multiple Search Types: Search by drug name, organization, mechanism of action, clinical trial, or FDA approval.
• API Metadata: Includes trial milestones, marketing organizations, pharmacology, drug pricing, and molecular visualization.

Who Uses the Clinical Drug Experience Knowledgebase and Why?

CDEK is designed for a wide spectrum of professionals across the biopharmaceutical ecosystem:

• Drug discovery researchers use it to identify historical trials and failed compounds.
• Regulatory scientists use it to track development pipelines and clinical progress.
• Business development teams assess competitive landscapes.
• Health data analysts use it to correlate drug development with adverse event reports.

It also serves as a foundational layer for professionals working with other tools like the Canada Adverse Reaction Database and large-scale clinical trial databases.

Who Uses the Clinical Drug Experience Knowledgebase—and Why?

CDEK’s web interface is built for intuitive exploration. Below are some of the most useful entry points:

1. Search by Drug Name

This is the default entry for most users. Typing in a drug like Remdesivir brings up a dedicated API page with:

• Active Ingredient History
• Trial Milestones
• All Trials (including failed or inactive)
• Marketing Organizations
• Pharmacology and Chemistry
• Pricing per Unit
• Interactive Molecule Viewer

Visit the drug search

2. Search by Organization in the Clinical Drug Experience Knowledgebase

You can filter by developer, sponsor, or investigator. Want to see what Genentech has in its clinical pipeline? This view will surface all affiliated compounds.

Explore organizations

3. Mechanism of Action (MoA)

This tab allows you to explore drugs based on how they work in the body. Perfect for pharmacologists or when researching drug repurposing.

Search by MoA

4. Clinical Trials

This allows browsing or filtering by trial phase, trial status, and more. It’s especially helpful for identifying trends in early-stage development.

Browse clinical trials

5. FDA Approvals

For users interested in seeing which of these compounds were ultimately approved by the FDA—and when.

Check FDA Approvals

Why the Clinical Drug Experience Knowledgebase Matters Today

The pharmaceutical landscape is increasingly competitive and data-driven. Legacy tools often only focus on approved drugs. CDEK fills the void by shining a light on drugs that are in development, discontinued, or in trial limbo.

This broader view empowers researchers and companies to:

• Avoid duplication by recognizing previously failed or unsuccessful compounds.
• Spot emerging competitors earlier in the development lifecycle.
• Build better hypotheses for drug repurposing based on historical data.

Moreover, in an age of transparency and open science, CDEK sets a gold standard by being open-access and freely available.

Real-World Example: What Can You Learn About a Drug?

Let’s say you’re investigating the API Sotorasib.

With a single search on CDEK, you’ll uncover:

• Its clinical trial history, including both successful and terminated studies.
• Which companies backed it.
• Its mechanism of action as a KRAS G12C inhibitor.
• Pricing information and pharmacologic properties.

This kind of transparency enables faster, more informed decision-making across the board—from academic researchers to biotech investors.

Integration with Other Research Tools

CDEK’s insights become even more powerful when integrated with:

• Adverse reaction databases: Correlate with safety data from Canada or FDA.
• Global trial registries: Map global trial activities alongside FDA pipelines.
• Cheminformatics platforms: Leverage molecule data for further in silico analysis.

For those working in multidisciplinary teams, CDEK becomes an essential node in a much larger network of pharmaceutical intelligence.

Final Thoughts

The Clinical Drug Experience Knowledgebase is more than just a dataset—it’s a lens into the soul of drug development. It enables science-forward, data-literate organizations to operate smarter, not harder.

With transparent access to trial histories, pharmacology, and commercial pathways, CDEK changes how we ask questions about drug efficacy, market trends, and medical innovation.

If you care about what happens before a drug hits the pharmacy shelf—this database is where your search should begin.

For deeper insight into FDA regulatory decisions and drug approval outcomes, explore our FDA Complete Response Letter Database Guide.

Sources

• Clinical Drug Experience Knowledgebase (CDEK), Purdue University
• “Purdue University Launches Open Access Database Cataloging Clinically Tested Pharmaceutical Ingredients” – Cloudways News

The post Clinical Drug Experience Knowledgebase: Explore Trial Data appeared first on The Database Search.